Incident Antipsychotic Use

Project Title Incident Antipsychotic Use
Date Posted
Friday, May 20, 2016
Status
Complete
Deliverables
Description

Modular program-based one-time assessment of the incident use of antipsychotics, including aripiprazole, asenapine, clozapine, iloperidone, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone, among patients without a pre-existing condition of schizophrenia spectrum disorder or bipolar I disorder and those with a pre-existing condition of schizophrenia spectrum disorder or bipolar I disorder. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of August 1, 2009 to September 30, 2011.  Modular programs are adaptable standardized programs. Results were generated using Modular Program 3; click here for more information.  Queries were distributed in October 2012. This report includes data from 16 Data Partners.
 
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.
 
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
antipsychotic
aripiprazole
asenapine
clozapine
iloperidone
lurasidone
olanzapine
paliperidone
quetiapine
risperidone
ziprasidone
Population / Cohort
All individuals
Time Period
August 1, 2009 - September 30, 2011
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER
Scroll to Top